Collaboration aims to advance patient-centered clinical research, making it more accessible, understandable and actionable for families
HERSHEY, Pa. — Tuesday, July 7, 2026 — Beat Childhood Cancer (BCC) at Penn State College of Medicine, an international pediatric cancer research consortium comprising more than 50 hospitals and research institutions across North America, South America and Europe, continues to explore innovative approaches that expand access to clinical trials and accelerate the development of new therapies for children with cancer. Today, Beat Childhood Cancer announced the implementation of the WeTrials AI-powered patient engagement platform to help families discover, understand and engage with pediatric cancer clinical research opportunities across the consortium’s study portfolio.